000 02061 a2200553 4500
005 20250518054136.0
264 0 _c20201007
008 202010s 0 0 eng d
022 _a1534-6080
024 7 _a10.1097/TP.0000000000002917
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCastro-Rojas, Cyd M
245 0 0 _amTOR Inhibitor Therapy Diminishes Circulating CD8+ CD28- Effector Memory T Cells and Improves Allograft Inflammation in Belatacept-refractory Renal Allograft Rejection.
_h[electronic resource]
260 _bTransplantation
_c05 2020
300 _a1058-1069 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAbatacept
_xpharmacology
650 0 4 _aBiopsy
650 0 4 _aCD28 Antigens
_ximmunology
650 0 4 _aCD8-Positive T-Lymphocytes
_ximmunology
650 0 4 _aFemale
650 0 4 _aGraft Rejection
_xdrug therapy
650 0 4 _aGraft Survival
650 0 4 _aHumans
650 0 4 _aImmunologic Memory
_xdrug effects
650 0 4 _aImmunosuppression Therapy
_xmethods
650 0 4 _aImmunosuppressive Agents
_xpharmacology
650 0 4 _aKidney
_xpathology
650 0 4 _aKidney Transplantation
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aSirolimus
_xpharmacology
650 0 4 _aT-Lymphocytes, Regulatory
_xdrug effects
650 0 4 _aTOR Serine-Threonine Kinases
_xantagonists & inhibitors
650 0 4 _aTacrolimus
_xpharmacology
650 0 4 _aTransplantation, Homologous
650 0 4 _aTreatment Outcome
700 1 _aGodarova, Alzbeta
700 1 _aShi, Tiffany
700 1 _aHummel, Sarah A
700 1 _aShields, Adele
700 1 _aTremblay, Simon
700 1 _aAlloway, Rita R
700 1 _aJordan, Michael B
700 1 _aWoodle, E Steve
700 1 _aHildeman, David A
773 0 _tTransplantation
_gvol. 104
_gno. 5
_gp. 1058-1069
856 4 0 _uhttps://doi.org/10.1097/TP.0000000000002917
_zAvailable from publisher's website
999 _c30007875
_d30007875